We also observed that the number of status of Her2 expressed positive in patients with DCIS and DCIS-Mi was higher than in those with IDC (P <0.001) but we found that the tumor size and family history of breast cancer in a first-degree relative seemed to have no difference in the three groups (P >0.05). This evidence concerns the gene ERBB2 and breast carcinoma.